Live feed
Filing
SC 13D
SC 13D0000947871-20-000948·ORBIMED ADVISORS LLC
Schedule 13D ownership disclosure
ARS Pharmaceuticals Inc
Security class unavailable · CUSIP: 82835W108
Event date: 2020-12-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 22.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-20-000948
- Form type
- SC 13D
- Filer
- ORBIMED ADVISORS LLC
- CIK
- CIK 1055951
- Filed
- Dec 11, 2020
- Reporting period
- Dec 03, 2020
- Description
- Schedule 13D beneficial ownership